X linked lymphoproliferative disease in a United Kingdom family

Archives of Disease in Childhood

Volumn 79, Issue 1, 1998, Pages 52-55

  Arkwright, Peter D ^a,b   Makin, Guy ^b,d   Will, Andrew M ^b,d   Ayres, Michelle ^c   Gokhale, David A ^c   Fergusson, William D ^c   Taylor, G Malcolm ^a,c  

^a ST MARY S HOSPITAL   (United Kingdom)

^b Department of Child Health ^*

^c Immunogenetics Laboratory

^d ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Bone marrow transplantation; Epstein Barr virus; Restriction fragment length polymorphism; X linked lymphoproliferative disease

Indexed keywords

ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CHILD; EPSTEIN BARR VIRUS; GENE LOCATION; GENETIC LINKAGE; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MALE; NEWBORN; PHENOTYPE; PRIORITY JOURNAL; X CHROMOSOMAL INHERITANCE;

EID: 0031822733     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.79.1.52     Document Type: Article

References (19)

1. Seemayer TA, Gross TG, Egeler RM, et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res 1995;38:471-7.
2. Bar RS, DeLor CJ, Clausen KP, et al. Fatal infectious mononucleosis in a family. N Engl J Med 1974;290:363-7.
3. Purtilo DT, Cassel CK, Yang JPS, et al. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1975;i:935-40.
4. Purtilo DT, DeFlorio D, Lindsey M, et al. Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome. N Engl J Med 1977;297:1077-81.
5. Okano M, Gross TG. Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. Am J Hematol 1996;53:111-15.
6. Seemayer TA, Gierson H, Pirruccullo SJ, et al. X-linked lymphoproliferative disease. Am J Dis Child 1993;147: 1242-5.
7. Grierson HL, Skare JC, Davis JR, et al. Evaluation of families wherein a single male manifests a phenotype of X-linked lymphoproliferative disease (XLP). Am J Med Genet 1993;47:458-63.
8. Purtilo DT, Sakamoto K, Barnabei V, et al. Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP). Am J Med 1982;73:49-55.
9. Pracher E, Panzer-Grumayer ER, Zoubek A, et al. Successful bone marrow transplantation in a boy with X-linked lymphoproliferative syndrome and acute severe infectious mononucleosis. Bone Marrow Transplant 1994;13:655-8.
10. Gross TG, Filipovich AH, Conley ME, et al. Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. Bone Marrow Transplant 1996;17:741-4.
11. Blin N, Stafford DN. A general method for isolation of high molecular weight DNA from eukaryotes. Nucl Acids Res 1976;3:2303-8.
12. Kunkel LM, Lalande M, Monaco AP, et al. Construction of a human X-chromosome-enriched phage library which facilitates analysis of specific loci. Gene 1985;33:251-8.
13. Boggs BA, Nussbaum RL. Two anonymous X-specific human sequences detecting restriction fragment length polymorphisms in region Xq26-ter. Somat Cell Mol Genet 1984;10:607-13.
14. Oberle I, Arveiler B, Mattei MG, et al. Linkage analysis of the fragile X-mental retardation syndrome with flanking polymorphic DNA markers. Cytogenet Cell Genet 1985;40: 715.
15. Henter J-I, Arico M, Egeler RM, et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 1997;28:342-7.
16. Lamartine J, Nichols KE, Yin L, et al. Physical map and cosmid contig encompassing a new interstitial deletion of the X-linked lymphoproliferative syndrome region. Eur J Hum Genet 1996;4:342-51.
17. Khanna R, Burrows SR, Moss DJ. Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev 1995; 59:387-405.
18. Purtilo DT. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients. AIDS Res 1986;2(suppl 1):177-82.
19. Ando I, Morgan G, Levinsky RJ, Crawford DH. A family study of the X-linked lymphoproliferative syndrome: evidence for a B cell defect contributing to the immunodeficiency. Clin Exp Immunol 1998;63:271-9.